Pathophysiology and treatment of painful diabetic neuropathy of the lower extremity

Southern Medical Journal

Volumn 91, Issue 10, 1998, Pages 894-898

  Wunderlich, Robert P ^a,b   Peters, Edgar J G ^a   Bosma, Jan ^a   Armstrong, David G ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CAPSAICIN; CARBAMAZEPINE; CITALOPRAM; CLOMIPRAMINE; DERMATOLOGICAL AGENT; DESIPRAMINE; DEXTROMETHORPHAN; EPALRESTAT; FLUOXETINE; FLUPHENAZINE; IBUPROFEN; IMIPRAMINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MEXILETINE; MIANSERIN; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; PAROXETINE; PHENYTOIN; SORBINIL; SULINDAC; THIOCTIC ACID;

CLINICAL TRIAL; DIABETIC NEUROPATHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEG DISEASE; PAIN; PATHOPHYSIOLOGY; REVIEW; TRANSCUTANEOUS NERVE STIMULATION;

EID: 0031688629     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199810000-00001     Document Type: Review

References (54)

1. Goodman JI, Baumoel S, Frankel L, et al: The Diabetic Neuropathies. Springfield, Ill, Charles C. Thomas Publisher, 1953
2. Boulton AJM, Knight G, Drury J, et al: The prevalence of symptomatic diabetic neuropathy in an insulin treated population. Diabetes Care 1985; 8:125-128
3. O'Hare JA, Abuaisha F, Geoghegan M: Prevalence and forms of neuropathic morbidity in 800 diabetics. Ir J Med Sci 1994; 163:132-135
4. Harris M, Eastman R, Cowie C: Symptoms of sensory neuropathy in adults with NIDDM in the U. S. population. Diabetes Care 1993; 16:1446-1452
5. Boulton AJ, Ward JD: Diabetic neuropathies and pain. Clin Endocrinol Metab 1986; 15:917-931
6. Armstrong DG, Lavery LA, Fleischli JG, et al: Is electrical stimulation effective in reducing neuropathic pain in patients with diabetes? J Foot Ankle Surg 1997; 36:260-263
7. Gabbay KH, Merola LO, Field RA: Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes. Science 1966; 151:209-210
8. Stewart MA, Sherman WR, Anthony S: Free sugars in alloxan diabetic rat nerve. Biochem Biophys Res Commun 1966; 22:4-91
9. Yacyahishi S, Wada R, Kamijo M, et al: Peripheral neuropathy in the WBN/Kob rat with chronic pancreatitis and spontaneous diabetes. Lab Invest 1993; 63:296-307
10. Berti-Mattera LN, Harati Y, Eichberg J: Decreased polyphosphoinositide metabolism accompanies myelinated fiber loss in human peripheral neuropathies. Mol Chem Neuropathol 1992; 17:201-208
11. Eichberg J, Hauser G: The subcellular distribution of polyphosphoinositides in myelinated and unmyelinated rat brain. Biochim Biophys Acta 1973; 326:210-223
12. Kai M, Hawthorne JN: Physiological significance of polyphosphoinositides in brain. Ann NY Acad Sci 1969; 165:761-773
13. Ward JD, Baker RWR, David B: Effect of blood sugar control on the accumulation of sorbitol and fructose in nervous tissue. Diabetes 1972; 21:1173-1178
14. Holman RR, Dornan TL, Mayon-White V, et al: Prevention of deterioration of renal and sensory nerve function by more intensive management of insulin-dependent diabetic patients. a two year randomized prospective study. Lancet 1983; 1:204-208
15. Woltman HW, Wilder RM: Diabetes mellitus: pathological changes in the spinal cord and peripheral nerves. Arch Intern Med 1929; 44:576
16. Harriman D: Ischaemic factor in diabetic neuropathy. Proceedings of the Fourth International Congress of Neuropathology. Stuttgart, G. Thieme, 1962, p 164
17. Dolman CL: The morbid anatomy of diabetic neuropathy. Neurology 1963; 13:135
18. Vital C, Brechenmacher C, Serise JM, et al: Ultrastructural study of peripheral nerve in arteritic diabetic patients. Acta Neuropathol 1983; 61:225-231
19. Jakobsen J, Lundbaek K: Neuropathv in experimental diabetes: an animal model. BMJ 1976; 2:278-279
20. Sugimura K, Windebank AJ, Natarajan V, et al: Interstitial hyperosmolarity may cause axis cylinder shrinkage in streptozotocin diabetic nerve. J Neuropathol Exp Neurol 1980; 39:710-721
21. Thomas PK, Eliasson SG: Diabetic neuropathy. Diseases of the Peripheral Nervous System. Dyck PJ (ed). Philadelphia, WB Saunders Co, 1987, pp 1773-1810
22. Weber GA, Cardile MA: Diabetic neuropathies. Clin Podiatr Surg 1990;7:1-36
23. Asbury AK, Fields HL: Pain due to peripheral nerve damage. Neurology 1984; 34:1587-1590
24. Pfeifer MA, Ross DR, Schrage JP, et al: A highly successful and novel model for treatment of chronic painful diabetic peripheral neuropathy. Diabetes Care 1993; 16:1103-1115
25. Boulton AJM, Drury J, Clarke B, et al: Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care 1982; 5:386-390
26. Capsaicin Study Group: Treatment of painful diabetic neuropathy with topical capsaicin. a multicenter, double-blind, vehicle-controlled study. Arch Intern Med 1991; 151:2225-2229
27. Cohen KL, Harris S: Efficacy and safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy. Arch Intern Med 1987; 147:1442-1444
28. Chadda VS, Mathur MS: Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy. J Assoc Physicians India 1978; 26:403-406
29. Dejgard A, Petersen P, Kastrup J: Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet 1988; 1:9-11
30. Gomez-Perez FJ, Rull JA, Dies H, et al: Nontriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. Pain 1985; 23:395-400
31. Gomez-Perez FJ, Choza R, Rios JM, et al: Nortriptyline-fluphenazine vs. carbamazepine in the symptomatic treatment of diabetic neuropathy. Arch Med Res 1996; 27:525-529
32. Kastrup J, Angelo HR, Petersen P: Treatment of chronic painful diabetic neuropathy with intravenous lidocaine infusion. BMJ 1986; 292:173-178
33. Kvinesdal B, Molin J, Froland A, et al: Imipramine treatment of painful diabetic neuropathy. JAMA 1984; 251:1727-1730
34. Max MB, Lynch SA, Muir J, et al: Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992; 326:1250-1256
35. Nelson KA, Park KM, Robinovitz E, et al: High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997; 48:1212-1218
36. Oskarsson P, Ljunggren JG, Lins PE: Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. the Mexiletine Study Group. Diabetes Care 1997; 20:1594-1597
37. Scheffler NM, Sheitel PL, Lipton MN: Treatment of painful diabetic neuropathy with capsaicin 0.075%. J Am Podiatr Med Assoc 1991; 81:288-293
38. Sindrup SH, Tuxen C, Gram LF, et al: The effect of mianserin on the symptoms of diabetic neuropathy. Eur J Clin Pharmarol 1992; 43:251-255
39. Sindrup SH, Bjerre U, Dejgaarde A, et al: The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 1992; 52:547-552
40. Sindrup SH, Gram LF, Brosen K, et al: The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990; 42:135-144
41. Sindrup SH, Gram LF, Skjold T, et al: Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms. Clin Pharmacol Ther 1990; 47:509-551
42. Sindrup SH, Gram LF, Skjold T, et al: Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms, a double-blind cross-over study. Br J Clin Pharmacol 1990; 30:683-691
43. Stracke H, Meyer UE, Schumacher HE, et al: Mexiletine in the treatment of diabetic neuropathy. Diabetes Care 1992; 15:1550-1555
44. Uchida K, Kigoshi T, Nakano S, et al: Effect of 24 weeks of treatment with epalrestat, an aldose reductase inhibitor, on peripheral neuropathy in patients with non-insulin dependent diabetes mellitus. Clin Ther 1995; 17:460-466
45. Wilton TD: Tegretol in the treatment of diabetic neuropathy. S Afr Med J 1974; 48:869-872
46. Wright JM, Oki JC, Graves L: Mexiletine in the symptomatic treatment of diabetic peripheral neuropathy. Ann Pharmarother 1997; 31:29-32
47. Young RJ, Ewing DJ, Clarke BF: A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy. Diabetes 1983; 32:938-942
48. Ziegler D, Gries FA: α-Lipoic acid in the treatment of diabetic peripheral and cardiac autonomie neuropathy. Diabetes 1997; 46:S62-S66
49. Melzack R, Wall PD: Pain mechanisms: a new theory. Science 1965; 150:971-979
50. Finsen V, Persen L, Løvlien M, et al: Transcutaneous electrical nerve stimulation after major amputation. J Bone Joint Surg Br 1988; 70:109-112
51. Bussey JG Jr, Jackson A: TENS for post surgical analgesia. Contemp Surg 1981; 18:35-41
52. Naidu KR: Transcutaneous electrical stimulation in the management of phantom limb pain. J Assoc Physicians India 1982; 30:309-313
53. Thorsteinsson G: Mangement of painful diabetic neuropathy (Letter). JAMA 1977; 238:2697
54. Kumar D, Marshall HJ: Diabetic peripheral neuropathy: amelioration of pain with transcutaneous electrostimulation. Diabetes Care 1997; 20:1702-1705